{"id":13097,"name":"BioAdvance","slug":"bioadvance","website":"https://bioadvance.com/","hqGeo":"Philadelphia, PA","stageFocus":["Seed"],"sectorTags":["Healthcare"],"excludedSectors":["Consumer","Media"],"checkSizeMin":250000,"checkSizeMax":1000000,"thesisSummary":"Invests in early-stage life sciences companies with potential for high impact in health and biotechnology.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Halo Labs","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ImmunoGenesis","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"IVIEW Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Latus Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Uses next-generation AAV capsid technology for CNS disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ossianix","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"BioAdvance follow-on investment","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Palvella Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Strados Labs","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Tolerance Bio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Pioneers thymus restoration therapies to improve immune health and longevity","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vittoria Biotherapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Keriton, Inc.  (CIK 0001690238)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning BioAdvance","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"WellTrackONE Corp  (CIK 0001602928)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning BioAdvance","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Hanimune Therapeutics Inc  (CIK 0001769072)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning BioAdvance","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Agnos Bio","companyUrl":null,"stage":"Not stated","sector":"Therapeutics / cell therapy","investmentYear":null,"description":"Develops mutation-agnostic, off-the-shelf cell therapies to restore sight in inherited blindness","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aspicio Therapeutics","companyUrl":null,"stage":"Not stated","sector":"Therapeutics","investmentYear":null,"description":"Develops a biologic therapy for dry age-related macular degeneration","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ChyloMetis","companyUrl":null,"stage":"Not stated","sector":"Therapeutics","investmentYear":null,"description":"Develops non-immunosuppressive therapies for chronic gastrointestinal disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Hula Therapeutics","companyUrl":null,"stage":"Not stated","sector":"Therapeutics / oncology","investmentYear":null,"description":"Works on tumor-specific targets for precision therapeutics, including cell therapy, T-cell engagers, and ADCs","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Imtol","companyUrl":null,"stage":"Not stated","sector":"Therapeutics / autoimmune","investmentYear":null,"description":"Engineers pan-antigen therapies for autoimmune disease","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ordaos","companyUrl":null,"stage":"Not stated","sector":"Platform / drug discovery","investmentYear":null,"description":"Uses AI to design mini-proteins and single-domain antibodies for drug discovery","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Overwatch Health","companyUrl":null,"stage":"Not stated","sector":"Health IT / digital health","investmentYear":null,"description":"Expands access to rehabilitative care through AI-assisted virtual solutions for cardiac and pulmonary conditions","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Spirovant","companyUrl":null,"stage":"Not stated","sector":"Gene therapy","investmentYear":null,"description":"Develops gene therapies for cystic fibrosis and other pulmonary diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ENB Therapeutics","companyUrl":null,"stage":"Existing portfolio / follow-on","sector":"Not stated","investmentYear":null,"description":"BioAdvance follow-on investment","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"RightAir","companyUrl":null,"stage":"Existing portfolio / follow-on","sector":"Not stated","investmentYear":null,"description":"BioAdvance follow-on investment","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Venatorx Pharmaceuticals","companyUrl":null,"stage":"Existing portfolio / follow-on","sector":"Not stated","investmentYear":null,"description":"BioAdvance follow-on investment","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":3,"partners":[{"id":42813,"name":"Barbara Schilberg","title":"CEO","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":42814,"name":"Frederick Jones","title":"Advisory Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/frederick-rick-jones-a82310a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":42815,"name":"Jeannette McClintock","title":"Managing Director","seniority":null,"focusTags":["HealthTech","BioTech"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Other","Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":13015,"name":"Nile Ventures","slug":"nile-ventures-13015","logoUrl":null,"website":"https://www.choosenile.com/","stageFocus":["Pre-Seed"],"sectorTags":["Healthcare","SaaS"],"hqGeo":"Lagos, Nigeria"},{"id":9065,"name":"Sdv","slug":"sdv","logoUrl":null,"website":"https://sdv.vc","stageFocus":["Pre-Seed","Seed"],"sectorTags":["SaaS","Fintech","Healthcare","AI / ML"],"hqGeo":null},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Other","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":10202,"name":"Celestial Health Innovators","slug":"celestial-health-innovators","logoUrl":null,"website":"https://celestialhealthwellness.co/","stageFocus":["seed+","Series A"],"sectorTags":["Healthcare","Other"],"hqGeo":"New York, NY"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Other","Healthcare"],"hqGeo":"Austin, TX"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-09-03T02:53:41.416Z"}